|
|
||||||||
,
,
,
,
* Arthritis Centre of Excellence, Toronto Western Hospital Research Institute, Toronto Western Hospital and
Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada; and
Department of Medicine and
Department of Immunology, University of Toronto, Toronto, Ontario, Canada
Polyclonal B cell activation is a well-described feature of systemic lupus erythematosus (SLE), but the immune mechanisms leading to this activation are unclear. To gain insight into these processes, we extensively characterized the activated peripheral blood B cell populations in SLE. PBMC from lupus patients and healthy controls were stained with various combinations of conjugated Ab to identify distinct peripheral B cell subsets, and activation was assessed by measurement of forward scatter and CD80 or CD86 expression using flow cytometry. SLE patients had altered proportions of several B cell subsets, many of which demonstrated increased activation as assessed by forward scatter. This activation occurred at an early developmental stage, as B cells in the transitional (T2) stage were already significantly larger than those seen in controls. Increased proportions of CD80- or CD86-expressing cells were also seen in multiple B cell subsets, with the most striking differences observed in the naive CD27–CD23+ population. Within the CD23+ subset, increased costimulatory molecule expression was most pronounced in an IgD+IgMlow population, suggesting that activation follows Ag engagement. Although controls also had IgD+IgMlowCD23+ cells, they were reduced in number and not activated. Thus, there is an altered response to Ig receptor engagement with self-Ags in lupus.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by a grant from the Canadian Institutes of Health Research (CIHR; to J.E.W). J.E.W. is the recipient of an Arthritis Society/CIHR Investigator Award. P.R.F. is the recipient of a combined The Arthritis Society/CIHR Institute of Musculoskeletal Health and Arthritis Investigator Award. N.-H.C. is the recipient of an Arthritis Centre of Excellence Fellowship.
2 Address correspondence and reprint requests to Dr. Joan E. Wither, Departments of Medicine and Immunology, University of Toronto, 1E420, Toronto Western Hospital, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada. E-mail address: jwither{at}uhnres.utoronto.ca
3 Abbreviations used in this paper: SLE, systemic lupus erythematosus; BAFF, B cell-activating factor; T2, transitional type 2; SLEDAI-2K, SLE disease activity index-2K; FSC, forward scatter; int, intermediate; T1, transitional type 1; GC, germinal center.
This article has been cited by other articles:
![]() |
E. L. Carpenter, R. Mick, A. J. Rech, G. L. Beatty, T. A. Colligon, M. R. Rosenfeld, D. E. Kaplan, K.-M. Chang, S. M. Domchek, P. A. Kanetsky, et al. Collapse of the CD27+ B-Cell Compartment Associated with Systemic Plasmacytosis in Patients with Advanced Melanoma and Other Cancers Clin. Cancer Res., July 1, 2009; 15(13): 4277 - 4287. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lee, S. Kuchen, R. Fischer, S. Chang, and P. E. Lipsky Identification and Characterization of a Human CD5+ Pre-Naive B Cell Population J. Immunol., April 1, 2009; 182(7): 4116 - 4126. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ahlmann, G. Varga, K. Sturm, R. Lippe, K. Benedyk, D. Viemann, T. Scholzen, J. Ehrchen, F. U. Muller, M. Seidl, et al. The Cyclic AMP Response Element Modulator {alpha} Suppresses CD86 Expression and APC Function J. Immunol., April 1, 2009; 182(7): 4167 - 4174. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Duty, P. Szodoray, N.-Y. Zheng, K. A. Koelsch, Q. Zhang, M. Swiatkowski, M. Mathias, L. Garman, C. Helms, B. Nakken, et al. Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors J. Exp. Med., January 16, 2009; 206(1): 139 - 151. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |